{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:39:52Z","timestamp":1788982792882,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tice.2026.103365","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:02:03Z","timestamp":1770397323000},"page":"103365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Overcoming osimertinib resistance in NSCLC: The role of Notch1 pathway inhibition by berberine"],"prefix":"10.1016","volume":"100","author":[{"given":"Xiaozhen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.103365_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103403","article-title":"NOTCH signaling: journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target","volume":"164","author":"Aggarwal","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"30","key":"10.1016\/j.tice.2026.103365_bib2","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.2174\/0115680266261150231110053650","article-title":"To investigate growth factor receptor targets and generate cancer targeting inhibitors","volume":"23","author":"Basu","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"issue":"7","key":"10.1016\/j.tice.2026.103365_bib3","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.7150\/jca.17741","article-title":"Expression of Notch gene and its impact on survival of patients with resectable non-small cell lung cancer","volume":"8","author":"Chen","year":"2017","journal-title":"J. Cancer"},{"issue":"8","key":"10.1016\/j.tice.2026.103365_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.21037\/atm-22-1298","article-title":"Berberine induces non-small cell lung cancer apoptosis via the activation of the ROS\/ASK1\/JNK pathway","volume":"10","author":"Chen","year":"2022","journal-title":"Ann. Transl. Med."},{"issue":"5","key":"10.1016\/j.tice.2026.103365_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/tox.23076","article-title":"Dual down-regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells","volume":"36","author":"Chuang","year":"2021","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.tice.2026.103365_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-022-01391-4","article-title":"Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance","volume":"15","author":"Fu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.tice.2026.103365_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/CAD.0000000000000835","article-title":"Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78","volume":"31","author":"Gong","year":"2020","journal-title":"AntiCancer Drugs"},{"issue":"15","key":"10.1016\/j.tice.2026.103365_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512190","article-title":"The effects of a curcumin derivative and osimertinib on fatty acyl metabolism and mitochondrial functions in HCC827 cells and tumors","volume":"24","author":"Hsieh","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.tice.2026.103365_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202500626","article-title":"Dual mechanism of amphiroa anceps: antiangiogenic and anticancer effects in skin cancer","volume":"22","author":"Janani","year":"2025","journal-title":"Chem. Biodivers."},{"issue":"2","key":"10.1016\/j.tice.2026.103365_bib10","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.18632\/oncotarget.12388","article-title":"Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling","volume":"8","author":"Jue","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.tice.2026.103365_bib11","first-page":"279","article-title":"Precision medicine for human cancers with Notch signaling dysregulation (Review)","volume":"45","author":"Katoh","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.tice.2026.103365_bib12","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.21037\/tlcr-21-536","article-title":"NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment","volume":"10","author":"Koba","year":"2021","journal-title":"Transl. lung Cancer Res."},{"key":"10.1016\/j.tice.2026.103365_bib13","article-title":"Traditional Chinese medicine and lung cancer--From theory to practice","volume":"137","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother. Biomede."},{"issue":"1","key":"10.1016\/j.tice.2026.103365_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7150\/ijbs.53477","article-title":"HES1 promotes breast cancer stem cells by elevating Slug in triple-negative breast cancer","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tice.2026.103365_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109543","article-title":"Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma","volume":"120","author":"Liu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tice.2026.103365_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117343","article-title":"Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo","volume":"244","author":"Lu","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.tice.2026.103365_bib17","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.immuni.2024.03.020","article-title":"Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages","volume":"57","author":"Mandula","year":"2024","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.tice.2026.103365_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110492","article-title":"Tumor-derived Jagged1 promotes cancer progression through immune evasion","volume":"38","author":"Meng","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tice.2026.103365_bib19","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.1016\/j.wneu.2024.04.146","article-title":"An Evaluation of risk factors for intracranial metastases of sarcomas: a systematic review and meta-analysis","volume":"187","author":"Nguyen","year":"2024","journal-title":"World Neurosurg."},{"issue":"4","key":"10.1016\/j.tice.2026.103365_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s43018-021-00195-8","article-title":"Overcoming therapy resistance in EGFR-mutant lung cancer","volume":"2","author":"Passaro","year":"2021","journal-title":"Nat. Cancer"},{"issue":"9","key":"10.1016\/j.tice.2026.103365_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.7150\/ijms.44683","article-title":"Notch1 affects chemo-resistance through regulating epithelial-mesenchymal transition (EMT) in Epithelial Ovarian cancer cells","volume":"17","author":"Qian","year":"2020","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.tice.2026.103365_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.tice.2026.103365_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237368","article-title":"Berberine as a potential anticancer agent: a comprehensive review","volume":"26","author":"Rauf","year":"2021","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.tice.2026.103365_bib24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJMra1703413","article-title":"Precision diagnosis and treatment for advanced non-small-cell lung cancer","volume":"377","author":"Reck","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.tice.2026.103365_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrc.2017.84","article-title":"Understanding and targeting resistance mechanisms in NSCLC","volume":"17","author":"Rotow","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.tice.2026.103365_bib26","first-page":"207","article-title":"Possible signaling cascades involved in attenuation of alloxan-induced oxidative stress and hyperglycemia in mice by ethanolic extract of Syzygium jambolanum: drug-DNA interaction with calf thymus DNA as target","volume":"44","author":"Samadder","year":"2011","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.tice.2026.103365_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jams.2013.04.004","article-title":"The potentized homeopathic drug, Lycopodium clavatum (5C and 15C) has anti-cancer effect on hela cells in vitro","volume":"6","author":"Samadder","year":"2013","journal-title":"J. Acupunct. Meridian Stud."},{"key":"10.1016\/j.tice.2026.103365_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.phrs.2018.03.021","article-title":"Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases","volume":"132","author":"Shah","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.tice.2026.103365_bib29","first-page":"2583","article-title":"Matrine prevents the early development of hepatocellular carcinoma like lesions in rat liver","volume":"18","author":"Shi","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.tice.2026.103365_bib30","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA a cancer journal clinicians"},{"issue":"2","key":"10.1016\/j.tice.2026.103365_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.tice.2026.103365_bib32","first-page":"557","article-title":"A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome","volume":"20","author":"Tabeshpour","year":"2017","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"4","key":"10.1016\/j.tice.2026.103365_bib33","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/cas.15674","article-title":"Notch pathway regulates osimertinib drug-tolerant persistence in EGFR-mutated non-small-cell lung cancer","volume":"114","author":"Takahashi","year":"2023","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.tice.2026.103365_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/jscr\/rjw116","article-title":"Lung cancer metastasis presenting as a solitary skull mass","volume":"2016","author":"Turner","year":"2016","journal-title":"J. Surg. Case Rep."},{"issue":"46","key":"10.1016\/j.tice.2026.103365_bib35","doi-asserted-by":"crossref","first-page":"76076","DOI":"10.18632\/oncotarget.12589","article-title":"Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.tice.2026.103365_bib36","doi-asserted-by":"crossref","first-page":"10135","DOI":"10.18632\/oncotarget.20807","article-title":"Metformin and berberine, two versatile drugs in treatment of common metabolic diseases","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.tice.2026.103365_bib37","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1016\/j.ejca.2013.07.007","article-title":"Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo","volume":"49","author":"Xie","year":"2013","journal-title":"Euro. J. Cancer"},{"issue":"14","key":"10.1016\/j.tice.2026.103365_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27144523","article-title":"Anticancer effects and mechanisms of berberine from medicinal herbs: an update review","volume":"27","author":"Xiong","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.tice.2026.103365_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.tice.2026.103365_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/aps.2016.125","article-title":"Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system","volume":"38","author":"Zou","year":"2017","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:44:22Z","timestamp":1773265462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S0040816626000571"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103365","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming osimertinib resistance in NSCLC: The role of Notch1 pathway inhibition by berberine","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103365"}}